missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ ABX 464
Description
ABX 464 is an HIV RNA splicing modulator; it selectively enhances the splicing of HIV RNA in infected human PBMCs and inhibits viral replication, with no global effect on cellular splicing. ABX 464 inhibits replication of HIV strains harboring mutations associated with drug-resistance. ABX 464 binds the cap binding complex (CBC) and upregulates miR-124 expression in vitro and decreases expression of miR-124 target genes, MCP-1, CXCL-1, SERPIN-E1 in macrophages. It also decreases the number of Th17 cells, as well as IL-6 soluble receptor in CD4+ T cells. In HIV infected humanized mice, treatment with ABX 464 reduces viral load. Anti-inflammatory.
Specifications
Specifications
| Chemical Name or Material | 8-Chloro-N-[4-(trifluoromethoxy)phenyl]-2-quinolinamine |
| CAS | 1258453-75-6 |
| Quantity | 10 mg |
| Target | DNA, RNA and Protein Synthesis Compounds |
| Molecular Formula | C16H10ClF3N2O |
| Purity | 0.98 |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?